PMID- 16415155 OWN - NLM STAT- MEDLINE DCOM- 20060317 LR - 20181113 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 103 IP - 4 DP - 2006 Jan 24 TI - The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. PG - 1018-23 AB - Menin is the product of the tumor suppressor gene Men1 that is mutated in the inherited tumor syndrome multiple endocrine neoplasia type 1 (MEN1). Menin has been shown to interact with SET-1 domain-containing histone 3 lysine 4 (H3K4) methyltransferases including mixed lineage leukemia proteins to regulate homeobox (Hox) gene expression in vitro. Using conditional Men1 knockout mice, we have investigated the requirement for menin in hematopoiesis and myeloid transformation. Men1 excision causes reduction of Hoxa9 expression, colony formation by hematopoietic progenitors, and the peripheral white blood cell count. Menin directly activates Hoxa9 expression, at least in part, by binding to the Hoxa9 locus, facilitating methylation of H3K4, and recruiting the methylated H3K4 binding protein chd1 to the locus. Consistent with signaling downstream of menin, ectopic expression of both Hoxa9 and Meis1 rescues colony formation defects in Men1-excised bone marrow. Moreover, Men1 excision also suppresses proliferation of leukemogenic mixed lineage leukemia-AF9 fusion-protein-transformed myeloid cells and Hoxa9 expression. These studies uncover an important role for menin in both normal hematopoiesis and myeloid transformation and provide a mechanistic understanding of menin's function in these processes that may be used for therapy. FAU - Chen, Ya-Xiong AU - Chen YX AD - Abramson Family Cancer Research Institute, Department of Cancer Biology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. FAU - Yan, Jizhou AU - Yan J FAU - Keeshan, Karen AU - Keeshan K FAU - Tubbs, Anthony T AU - Tubbs AT FAU - Wang, Haoren AU - Wang H FAU - Silva, Albert AU - Silva A FAU - Brown, Eric J AU - Brown EJ FAU - Hess, Jay L AU - Hess JL FAU - Pear, Warren S AU - Pear WS FAU - Hua, Xianxin AU - Hua X LA - eng GR - R01 CA100912/CA/NCI NIH HHS/United States GR - CA100912/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060113 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Chd1 protein, mouse) RN - 0 (DNA-Binding Proteins) RN - 0 (Histones) RN - 0 (Homeodomain Proteins) RN - 0 (Men1 protein, mouse) RN - 0 (Proto-Oncogene Proteins) RN - 0 (homeobox protein HOXA9) RN - 9007-49-2 (DNA) RN - K3Z4F929H6 (Lysine) SB - IM MH - Animals MH - Blotting, Western MH - Cell Line, Transformed MH - Cell Proliferation MH - Chromatin Immunoprecipitation MH - DNA/metabolism MH - DNA Methylation MH - DNA-Binding Proteins/metabolism MH - Exons MH - Flow Cytometry MH - *Gene Expression Regulation MH - Genotype MH - *Hematopoiesis MH - Histones/chemistry MH - Homeodomain Proteins/metabolism/*physiology MH - Homozygote MH - Leukemia/metabolism MH - Lysine/chemistry MH - Methylation MH - Mice MH - Mice, Knockout MH - Mice, Transgenic MH - Models, Genetic MH - Models, Statistical MH - Myeloid Cells/metabolism MH - Proto-Oncogene Proteins/metabolism/*physiology MH - Retroviridae/genetics MH - Reverse Transcriptase Polymerase Chain Reaction MH - Stem Cells MH - Time Factors MH - Transgenes PMC - PMC1326489 EDAT- 2006/01/18 09:00 MHDA- 2006/03/18 09:00 PMCR- 2006/01/24 CRDT- 2006/01/18 09:00 PHST- 2006/01/18 09:00 [pubmed] PHST- 2006/03/18 09:00 [medline] PHST- 2006/01/18 09:00 [entrez] PHST- 2006/01/24 00:00 [pmc-release] AID - 0510347103 [pii] AID - 1018 [pii] AID - 10.1073/pnas.0510347103 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1018-23. doi: 10.1073/pnas.0510347103. Epub 2006 Jan 13.